Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients | Zendy

Lı́dia Ruiz | Zendy; Roger Paredes | Zendy; Guadalupe Gómez Melis | Zendy; Joan Romeu | Zendy; Peré Domingo | Zendy; Núria PérezÁlvarez | Zendy; Giuseppe Tambussi | Zendy; Josep M. Llibre | Zendy; Javier MartínezPicado | Zendy; Francesc Vidal | Zendy; Carmina R. Fumaz | Zendy; Bonaventura Clotet | Zendy

Open Access

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients

Author(s) -

Lı́dia Ruiz,

Roger Paredes,

Guadalupe Gómez Melis,

Joan Romeu,

Peré Domingo,

Núria PérezÁlvarez,

Giuseppe Tambussi,

Josep M. Llibre,

Javier MartínezPicado,

Francesc Vidal,

Carmina R. Fumaz,

Bonaventura Clotet

Publication year - 2006

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e328011033a

Subject(s) - medicine , confidence interval , hazard ratio , viral load , adverse effect , gastroenterology , antiretroviral therapy , immunology , reverse transcriptase inhibitor , human immunodeficiency virus (hiv)

We evaluated the safety of CD4 cell count and plasma HIV-1 RNA (pVL)-guided treatment interruptions (GTI) and determined predictors of duration of treatment interruption.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog